Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial.
Nature medicine · 2026 · 23 citations · John Tesser
Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
The Pediatric infectious disease journal · 2022 · 83 citations · Kaleo Ede
A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 46 citations · John Tesser
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 35 citations · John Tesser
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges.
Arthritis care & research · 2025 · 12 citations · Michael Shishov
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR).
The Journal of rheumatology · 2021 · 43 citations ·
A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings.
ACR open rheumatology · 2023 · 21 citations · John Tesser
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Rheumatology and therapy · 2023 · 18 citations · John Tesser